comparemela.com

Latest Breaking News On - Neopharm inc - Page 1 : comparemela.com

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors

SAN MATEO, Calif., March 25, 2024 Sagimet Biosciences Inc. , a clinical-stage biopharmaceutical company developing novel fatty acid synthase inhibitors designed to target dysfunctional.

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of

SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.